skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
Melan-A/MAGE-3.DP4 Peptide Vaccine (Code C96041)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Melan-A/MAGE-3.DP4 Peptide Vaccine

Definition: A cancer vaccine consisting of a peptide derived from the melanocyte differentiation antigen Melan-A (or MART-1) and the human leukocyte antigen HLA-DP4-restricted human melanoma antigen 3 (MAGE-3.DP4), with potential immunostimulating and antineoplastic activities. Upon administration, Melan-A/MAGE-3.DP4 peptide vaccine may stimulate the immune system to mount a cytotoxic T-cell (CTL) response against tumor cells expressing Melan-A and MAGE-3, resulting in tumor cell lysis. The tumor associated antigens Melan-A and MAGE-3 are overexpressed in a variety of cancer cell types.

Label: Melan-A/MAGE-3.DP4 Peptide Vaccine

NCI Thesaurus Code: C96041 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: CL428375  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Melan-A/MAGE-3.DP4 Peptide Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 697136
PDQ Open Trial Search ID 697136 (check for NCI PDQ open clinical trial info)

Other Properties:
     Name Value (qualifiers indented underneath)
code C96041
Semantic_Type Amino Acid, Peptide, or Protein
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom